Clinical Trials Logo

Clinical Trial Summary

- Background/Rationale: Epidemiological data about Primary Immunodeficiency Disorders (PIDD) in Kuwait is needed to better understand peculiarities and to compare them with other regions and ethnicity.

- Study hypothesis: PIDD is relatively common in Kuwait compared to populations from different geographic areas. The distribution of PIDD in Kuwait is different from other geographic areas with more severe forms being more frequent.

- Brief inclusion and exclusion criteria of study participants: PIDD patients presented at different clinics/hospital in Kuwait. Patients with secondary immunodeficiencies (drug induced, virus induced, and immunodeficiency associated with metabolic disorders... ect), will be excluded

- Estimated sample size of the study: All patients who were registered in KNPIDR since 2004 will be included in the study along with the new patients who will be recruited during the study period.

- Primary objectives:

- Determine the prevalence and frequency of different PIDD in Kuwait

- Identify clinical presentation patterns for PIDD in Kuwait

- Identify natural history of PIDD in Kuwait

- Help to asses epidemiology of PIDD in Kuwait

- Determine particularities about PIDD affecting the population in Kuwait

- Determine the health impact of PIDD in Kuwait

- Development of strategies to improve the care and the quality of life of patients with PIDD

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03618147
Study type Observational [Patient Registry]
Source Kuwait Society for Allergy and Clinical Immunology
Contact Waleed Al-Herz, MD
Phone 0096599937999
Status Recruiting
Start date July 16, 2018
Completion date July 15, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT03266653 - EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection Phase 2
Recruiting NCT03266640 - Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) Phase 2
Recruiting NCT03266627 - Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection Phase 2
Active, not recruiting NCT01859754 - Octagam 5% Versus Comparator Post Marketing Trial
Recruiting NCT03148028 - Immunological Characteristics of Patients With PID and IBD N/A
Active, not recruiting NCT01888484 - Study of Octanorm Subcutaneous IG in Patients With PID Phase 3
Completed NCT01131858 - Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency Phase 1/Phase 2
Not yet recruiting NCT03492710 - Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency Phase 3
Completed NCT03211689 - The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease N/A
Not yet recruiting NCT03939533 - Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases Phase 3
Recruiting NCT01883921 - Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)
Recruiting NCT02327351 - TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID Phase 2/Phase 3
Recruiting NCT03422614 - Pathophysiology of Inborn Immunodeficiencies N/A
Recruiting NCT02888535 - Intensive Care Unit and Secondary and Primary Immune Deficiency N/A
Recruiting NCT03069079 - Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study N/A
Recruiting NCT03037359 - A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products N/A
Recruiting NCT03414528 - Identification of New Inborn Errors of Immunity N/A
Active, not recruiting NCT03301168 - Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant Phase 1/Phase 2
Completed NCT01458171 - Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) Phase 3